Lin Yang

Durvalumab plus tremelimumab alone or in combination with low-dose or hypofractionated radiotherapy in metastatic non-small-cell lung cancer refractory to previous PD(L)-1 therapy: an open-label, multicentre, randomised, phase 2 trial

Jonathan D. Schoenfeld, Anita Giobbie‐Hurder, Srinika Ranasinghe et al. · The Lancet Oncology · 2022 · 225 citations · Full text

Medicine, Previous Pd, Bronchial Neoplasm +5

TISMO: syngeneic mouse tumor database to model tumor immunity and immunotherapy response

Zexian Zeng, Cheryl J. Wong, Lin Yang et al. · Nucleic Acids Research · 2021 · 123 citations · Full text

Discovery and validation of extracellular/circulating microRNAs during idiopathic pulmonary fibrosis disease progression

Guanghai Yang, Lin Yang, Wendong Wang et al. · Gene · 2015 · 122 citations

Fibrosis, Advanced Lung Disease, Medicine +7

scMAGeCK links genotypes with multiple phenotypes in single-cell CRISPR screens

Lin Yang, Yuqing Zhu, Hua Yu et al. · Genome biology · 2020 · 91 citations · Full text

Mechanisms of response and resistance to combined decitabine and ipilimumab for advanced myeloid disease

Livius Penter, Yang Liu, Jacquelyn O. Wolff et al. · Blood · 2023 · 48 citations · Full text

Mixed-phenotype Acute Leukemia, Immunology, Pharmacotherapy +20